Propel Bio Management, LLC 13F Holdings · Q2 2026
Propel Bio Management, LLC reported 29 securities worth $191.09M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: PAGP (16.16%), ACHV (13.79%), CORT (6.21%). Among its top 25 positions this quarter: 3 new, 11 added, 9 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HOLDINGS LP-CL | $30.9M | 16.16% | 1.3M | Hold |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC | $26.3M | 13.79% | 4.0M | Added |
| 3 | CORT | CORCEPT THERAPEUTICS INC | $11.9M | 6.21% | 136,499 | Trimmed |
| 4 | PHAT | PHATHOM PHARMACEUTICALS I | $11.4M | 5.96% | 1.1M | Added |
| 5 | DCTH | DELCATH SYSTEMS INC | $11.0M | 5.74% | 871,460 | Trimmed |
| 6 | MIST | MILESTONE PHARMACEUTICALS | $10.0M | 5.21% | 7.4M | Added |
| 7 | CMPS | COMPASS PATHWAYS PLC | $8.1M | 4.24% | 573,086 | Trimmed |
| 8 | KYTX | KYVERNA THERAPEUTICS INC | $7.9M | 4.12% | 883,198 | Added |
| 9 | ARTV | ARTIVA BIOTHERAPEUTICS IN | $6.8M | 3.54% | 696,436 | Added |
| 10 | ABEO | ABEONA THERAPEUTICS INC | $6.1M | 3.18% | 983,070 | Trimmed |
| 11 | AQST | AQUESTIVE THERAPEUTICS IN | $6.0M | 3.14% | 1.4M | Added |
| 12 | PALI | PALISADE BIO INC | $5.4M | 2.82% | 2.6M | Added |
| 13 | IMUX | IMMUNIC INC | $5.0M | 2.61% | 325,022 | New |
| 14 | IVA | INVENTIVA SA - ADR | $4.8M | 2.53% | 1.3M | Added |
| 15 | SABS | SAB BIOTHERAPEUTICS INC | $4.2M | 2.20% | 1.1M | Added |
| 16 | CLDX | CELLDEX THERAPEUTICS INC | $3.9M | 2.02% | 103,695 | Trimmed |
| 17 | OBIO | ORCHESTRA BIOMED HOLDINGS | $3.9M | 2.02% | 896,701 | Hold |
| 18 | ZVRA | ZEVRA THERAPEUTICS INC | $3.6M | 1.90% | 253,544 | Trimmed |
| 19 | OCUL | OCULAR THERAPEUTIX INC | $3.5M | 1.84% | 357,966 | Trimmed |
| 20 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $3.4M | 1.76% | 252,654 | Trimmed |
| 21 | OVID | OVID THERAPEUTICS INC | $3.0M | 1.57% | 1.1M | Added |
| 22 | EYPT | EYEPOINT INC | $2.7M | 1.43% | 191,745 | Trimmed |
| 23 | UPB | UPSTREAM BIO INC | $2.4M | 1.27% | 350,389 | Added |
| 24 | SCYX | SCYNEXIS INC | $2.2M | 1.16% | 543,478 | New |
| 25 | SLN | SILENCE THERAPEUTICS PLC | $2.1M | 1.10% | 191,733 | New |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR